Lennart A. Mulder

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

Journal: Nature communications
Published: October 13, 2025

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

Journal: NPJ breast cancer
Published: June 30, 2025

A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.

A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.

Journal: Breast cancer research : BCR
Published: November 22, 2024

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

Journal: EBioMedicine
Published: May 31, 2024

Improving selection procedures in health professions education from the applicant perspective: an interview study.

Improving selection procedures in health professions education from the applicant perspective: an interview study.

Journal: BMC medical education
Published: March 02, 2024

Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights.

Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights.

Journal: British journal of cancer
Published: July 24, 2023

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.

Journal: NPJ breast cancer
Published: March 31, 2023

PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning.

PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning.

Journal: Breast cancer research : BCR
Published: February 03, 2023

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

Journal: Cancer cell
Published: August 16, 2022

Tumour-educated platelets for breast cancer detection: biological and technical insights.

Tumour-educated platelets for breast cancer detection: biological and technical insights.

Journal: British journal of cancer
Published: January 28, 2022

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.

Journal: Nature genetics
Published: September 17, 2021

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.

Journal: NPJ breast cancer
Published: September 06, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026